Bioregulators vs Regular Peptides: The Hidden Science Revolution
The peptide therapy landscape shifted dramatically when the FDA began restricting injectable peptides in 2023-2024, leaving thousands of biohackers and anti-aging enthusiasts searching for alternatives. What they discovered changed everything: bioregulators, a class of ultra-short peptides developed over 40 years of Soviet research, offer comparable benefits to traditional injectable peptides while remaining completely legal as …